Pfizer – Amina Hamoutene, General Director – Algeria
19.01.2015
Related Interviews
Italy / Gilead's Valentino Confalone on Eliminating Viral Hepatitis by 2030, HIV Pipeline Potential, & the Future of CAR-T
Gilead Sciences’ vice president and general manager for Italy, Valentino Confalone, outlines the company’s tumultuous pandemic journey in one of the first global epicentres; the role that Italy played in…
Italy / Gilead's Valentino Confalone on Eliminating Viral Hepatitis by 2030, HIV Pipeline Potential, & the Future of CAR-T
Can you begin by commenting on Gilead’s footprint in Italy, a country where the company has been present for just two decades? Even though it is relatively young, Gilead is…
Mohamed Mostafa – Vice President and General Manager Saudi Arabia &…
IQVIA Vice President and General Manager Saudi Arabia & Egypt Mohamed Mostafa gives his expert insights into the transformation of the Saudi pharma market in recent years, covering everything from…
Vaccine Nationalism / “Moral Obscenity, Public Health Catastrophe & Economic Folly”
Over two years since the first cases of COVID-19, the world is still coming to terms with the virus. While vaccines have been developed and rolled out in record time…
Company Spotlight / Saudi Chemical Company Holding: At the Forefront of Saudi Healthcare’s Evolution
Saudi Chemical Company Holding (SCCH), Saudi Arabia’s leading manufacturer of civil and military explosives, has been expanding its pharma sector footprint in recent years. Today, the company has capabilities across…
Pharma Manufacturing in Africa / An Opportunity to Strengthen Global Pandemic Responses
Medicines for Africa’s Lenias Hwenda highlights the vast gaps in COVID-19 vaccine access globally, especially in Africa where just six percent of the population has been vaccinated. Hwenda argues that…
